Clinical trial
Comparison of Aripiprazole and Risperidone for the Treatment of People With…
NCT00320671 · Northwell Health, Other · Completed
Key facts
| NCT number | NCT00320671 |
|---|---|
| Title | Comparison of Aripiprazole and Risperidone for the Treatment of People With First-Episode Psychosis |
| Official title | Preventing Morbidity in First Episode Schizophrenia, Part II |
| Lead sponsor | Northwell Health, Other |
| Collaborators | National Institute of Mental Health (NIMH) NIH |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Schizophrenia |
| Intervention type | Drug |
| Interventions | Aripiprazole, Risperidone |
| Enrollment | 198 |
| Start date | Dec 1, 2005 |
| Primary completion | Dec 1, 2014 |
| Completion | Dec 1, 2015 |
| First posted | May 3, 2006 |
| Last update posted | Sep 8, 2016 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: